Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study)

[1]  F. Cavalli,et al.  Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy , 2013, Leukemia & lymphoma.

[2]  C. Copie-Bergman,et al.  Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  Ling-Feng Wang,et al.  Head and neck extranodal lymphoma in a single institute: A 17‐year retrospective analysis , 2012, The Kaohsiung journal of medical sciences.

[4]  A. Tzioufas,et al.  Prognosis and Outcome of Non-Hodgkin Lymphoma in Primary Sjögren Syndrome , 2012, Medicine.

[5]  A. López-Guillermo,et al.  High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study , 2011, Leukemia & lymphoma.

[6]  Keunchil Park,et al.  Involved-lesion radiation therapy after chemotherapy in limited-stage head-and-neck diffuse large B cell lymphoma. , 2010, International journal of radiation oncology, biology, physics.

[7]  Sheng-Tsung Chang,et al.  Upper aerodigestive tract lymphoma in Taiwan , 2010, Journal of Clinical Pathology.

[8]  Shulian Wang,et al.  Diffuse large B‐cell lymphoma , 2009, Cancer.

[9]  K. Olivier,et al.  Xerostomia in Long-term Survivors of Aggressive Non-Hodgkin's Lymphoma of Waldeyer's Ring: A Potential Role for Parotid-Sparing Techniques? , 2009, American journal of clinical oncology.

[10]  L. Rimsza,et al.  Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Y. Tamaki,et al.  Primary salivary gland lymphoma among Japanese: A clinicopathological study of 30 cases , 2007, Leukemia & lymphoma.

[12]  L. Medeiros,et al.  Extranodal lymphomas of the head and neck. , 2005, Annals of diagnostic pathology.

[13]  R. Gascoyne,et al.  Primary paranasal sinus lymphoma: natural history and improved outcome with central nervous system chemoprophylaxis , 2005, Leukemia & lymphoma.

[14]  R. Kanthan,et al.  Clonal B cell populations in a minority of patients with Hashimoto’s thyroiditis , 2004, Journal of Clinical Pathology.

[15]  L. Shih,et al.  Primary Salivary Gland Lymphoma: A Clinicopathologic Study of 23 Cases in Taiwan , 2004, Acta Haematologica.

[16]  H. Shirato,et al.  Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck. , 2004, International journal of radiation oncology, biology, physics.

[17]  J. Goepel,et al.  Localised extranodal lymphoma of the head and neck: the Sheffield Lymphoma Group experience (1971-2000). , 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

[18]  M. Boiocchi,et al.  Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. , 2004, Journal of the National Cancer Institute.

[19]  A. Weber,et al.  Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation. , 2003, Neuroimaging clinics of North America.

[20]  N. Harris,et al.  Lymphoma of the Nasal Cavity and Paranasal Sinuses: Treatment and Outcome of Early-Stage Disease , 2003, American journal of clinical oncology.

[21]  F. Cavalli,et al.  The modified International Prognostic Index can predict the outcome of localized primary intestinal lymphoma of both extranodal marginal zone B‐cell and diffuse large B‐cell histologies , 2002, British journal of haematology.

[22]  D. Hossfeld.  E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues , 2002 .

[23]  M. Aljurf,et al.  Localized non‐Hodgkin's lymphoma of Waldeyer's ring: Clinical features, management, and prognosis of 130 adult patients , 2001, Head & neck.

[24]  J. Armitage,et al.  Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  R. Fisher,et al.  Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. , 1998, The New England journal of medicine.

[26]  Jeffrey M. Hausdorff,et al.  Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy. , 1997, The cancer journal from Scientific American.

[27]  T M Grogan,et al.  Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.

[28]  M Tubiana,et al.  Report of the Committee on Hodgkin's Disease Staging Classification. , 1971, Cancer research.

[29]  L. Staudt,et al.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. , 2004, Blood.

[30]  A. Avilés,et al.  Treatment of non-Hodgkin's lymphoma of Waldeyer's ring: radiotherapy versus chemotherapy versus combined therapy. , 1996, European journal of cancer. Part B, Oral oncology.

[31]  D.,et al.  Regression Models and Life-Tables , 2022 .